Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
400
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
2016
0Study Completion Date
2016
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
diphenhydramine0
cetirizine0
ARC-5200
Interventional Trial Phase
Phase 10
Official Name
A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ARC-520 at Varying Infusion Rates in Normal Adult Volunteers0
Last Updated
February 26, 2018
0Allocation Type
Non-Randomized0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
Single doses of ARC-520 will be evaluated at varying infusion rates and by slow bolus push.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
